PIER MARIA FORNASARI

PIER MARIA FORNASARI
2019-08-17

New Frontiers of Corneal Gene Therapy

Source https://www.liebertpub.com/doi/pdf/10.1089/hum.2019.026#utm_source=ETOC&utm_medium=email&utm_campaign=hum Corneal diseases are among the most prevalent causes of blindness worldwide. The transparency and clarity of the cornea are guaranteed by a delicate physiological, anatomic, and functional balance. For this reason, all the disorders, including those of genetic origin, that compromise this state of harmony can lead to opacity and eventually vision loss.

No Comments InGENE THERAPY RARE DISEASES

PIER MARIA FORNASARI
2019-08-17

European Medicines Agency validates marketing application for Filgotinib for the treatment of rheumatoid arthritis

Gilead Sciences and Galapagos announced that the Marketing Authorization Application (MAA) for filgotinib, an investigational, oral, selective JAK1 inhibitor, for the treatment of adults with rheumatoid arthritis (RA) has been validated and is now under evaluation by the European Medicines Agency (EMA). “We are excited about the validation of this application which is an important

No Comments InWELLNESS

PIER MARIA FORNASARI
2019-08-17

Glia in the skin activate pain responses

Researchers from the Karolinska Institutet in Sweden have discovered a new nociceptive glio-neural complex that may only be skin deep. You’ve most likely quickly pulled your hand away when you’ve pricked it on a thorn bush, or if you fingertips get too close to fire. This is a natural reaction and generally means that your

No Comments InWELLNESS

PIER MARIA FORNASARI
2019-08-17

Virtual and augmented reality can save lives by improving surgeons’ training Justin Barad position

Source STAT Rapid advances in the development of medical devices in the 21st century are contributing to healthier lives, but bring with them a new challenge: teaching clinicians how to use these often-complicated technologies. Teaching them poorly, or failing to do it at all, can negate the potential benefits and put patients at risk of

No Comments InDIGITAL HEALTH

PIER MARIA FORNASARI
2019-08-16

Enhancing CAR T-cell therapy through cellular imaging and radiotherapy.

Source The Lancet. Oncology, ISSN: 1474-5488, Vol: 20, Issue: 8, Page: e443-e451 Chimeric antigen receptor (CAR) T-cell therapy is one of the most remarkable advances in cancer therapy in the last several decades. More than 300 adoptive T-cell therapy trials are ongoing, which is a testament to the early success and hope engendered by this

No Comments InCAR-T

PIER MARIA FORNASARI
2019-08-16

Social value decreases with delay of CAR-T cell therapy delivery

New research has observed that the benefits of CAR-T cell immunotherapies – for the treatment of diseases such as pediatric acute lymphoblastic leukemia and diffuse large B-cell lymphoma – may be offset by their delayed delivery to patients. The social value of a therapy balances manufacturer costs and profits versus a patient’s improvement in quality-adjusted

No Comments InCAR-T

PIER MARIA FORNASARI
2019-08-16

The “All of Us” Research Program : Progress report after 1 year

The vision is ambitious : Enroll 1 million people in the NIH’s All of Us Research program, whose goal is to make personalized medicine a reality for everyone. That means ensuring that more than half of participants come from communities historically underrepresented in biomedical research. A year after its launch, 230,000 people have joined, 80% of

No Comments InGENOME

PIER MARIA FORNASARI
2019-08-16

Relaxing of regulations for regenerative medicines has cascading effect internationally

Countries that relax regulations for regenerative medicines could be causing a downward spiral in international standards, according to new research published today. Researchers warn that if just one country decides to relax regulations in the field, a heightened sense of competition can spur others to do the same. It’s unclear whether this deregulation best serves

No Comments InREGENERATIVE MEDICINE

PIER MARIA FORNASARI
2019-08-16

Digital health gets new research hub

It has taken some time in finally getting its official launch, but government has opened the doors to a new public-private research hub aimed at using new digital technologies to build products and services to help keep elderly people in their own homes for longer. The Research Hub for Digital Enhanced Living being housed at Deakin University aims

No Comments InDIGITAL HEALTH

PIER MARIA FORNASARI
2019-08-15

New nanotechnology could aid stem cell transplantation research

Nanotechnology developed at Rutgers University-New Brunswick could boost research on stem cell transplantation, which may help people with Alzheimer’s disease, Parkinson’s disease, other neurodegenerative diseases and central nervous system injuries. The nanotechnology platform, which uses special tiny rods for sensing, allows researchers to confirm the identity of human stem cell fates and their biomarkers, or

No Comments InREGENERATIVE MEDICINE

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

All posts by PIER MARIA FORNASARI

New Frontiers of Corneal Gene Therapy

European Medicines Agency validates marketing application for Filgotinib for the treatment of rheumatoid arthritis

Glia in the skin activate pain responses

Virtual and augmented reality can save lives by improving surgeons’ training Justin Barad position

Enhancing CAR T-cell therapy through cellular imaging and radiotherapy.

The “All of Us” Research Program : Progress report after 1 year

Relaxing of regulations for regenerative medicines has cascading effect internationally

Digital health gets new research hub

New nanotechnology could aid stem cell transplantation research